PROSPECTIVE PHASE III EVALUATION OF FETAL FIBRONECTIN IN A HIGH RISK ASYMPTOMATIC POPULATION FOR THE PREDICTION OF SPONTANEOUS PRETERM BIRTH

Project: Other project

StatusFinished
Effective start/end date10/9/134/8/17

Funding

  • Hologic Incorporated: $78,846.00